Literature DB >> 21276005

The role of the PD-1 pathway in autoimmunity and peripheral tolerance.

Brian T Fife1, Kristen E Pauken.   

Abstract

Programmed death-1 (PD-1) is a surface receptor critical for the regulation of T cell function during immunity and tolerance. PD-1 interactions with its ligands PD-L1 and PD-L2 inhibit T cell effector functions in an antigen-specific manner. This paper examines the role of PD-1 in limiting autoreactivity and establishing self-tolerance and discusses the hypothesis that PD-1 ligand (PD-L) expression both spatially and temporally dictates the fate of self-reactive T cells during the breakdown of peripheral tolerance and development of autoimmunity. We focus our discussion on the role of PD-1/PD-L interactions during peripheral tolerance, the differential role for PD-L1 and PD-L2 in response to environmental or self-antigens, and the impact of PD-1 signaling on dynamic T cell motility and the T cell receptor (TCR) stop signal. Finally, we discuss the potential to selectively target the PD-1 pathway therapeutically to alter T cell function during autoimmunity.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276005     DOI: 10.1111/j.1749-6632.2010.05919.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  130 in total

1.  T-cell tolerance: central and peripheral.

Authors:  Yan Xing; Kristin A Hogquist
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

Review 2.  The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

Authors:  Craig L Slingluff
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

Review 3.  Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges.

Authors:  Siwen Hu-Lieskovan; Lidia Robert; Blanca Homet Moreno; Antoni Ribas
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

4.  PM2.5 affects establishment of immune tolerance in newborn mice by reducing PD-L1 expression.

Authors:  L I Yan; Caihui Gong; Linyan Ying; Wenlong Fu; Sha Liu; Jihong Dai; Zhou Fu
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

5.  Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

Authors:  Eric F Tewalt; Jarish N Cohen; Sherin J Rouhani; Cynthia J Guidi; Hui Qiao; Shawn P Fahl; Mark R Conaway; Timothy P Bender; Kenneth S Tung; Anthony T Vella; Adam J Adler; Lieping Chen; Victor H Engelhard
Journal:  Blood       Date:  2012-09-19       Impact factor: 22.113

6.  Protein Footprinting and X-ray Crystallography Reveal the Interaction of PD-L1 and a Macrocyclic Peptide.

Authors:  Ben Niu; Todd C Appleby; Ruth Wang; Mariya Morar; Johannes Voight; Armando G Villaseñor; Sheila Clancy; Sarah Wise; Jean-Philippe Belzile; Giuseppe Papalia; Melanie Wong; Katherine M Brendza; Latesh Lad; Michael L Gross
Journal:  Biochemistry       Date:  2019-12-31       Impact factor: 3.162

Review 7.  Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?

Authors:  Fabienne McClanahan; Thomas G Sharp; John G Gribben
Journal:  Haematologica       Date:  2016-10       Impact factor: 9.941

8.  Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Authors:  Kristen E Pauken; Christine E Nelson; Tijana Martinov; Vaiva Vezys; Brian T Fife; Justin A Spanier; James R Heffernan; Nathanael L Sahli; Clare F Quarnstrom; Kevin C Osum; Jason M Schenkel; Marc K Jenkins; Bruce R Blazar
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

Review 9.  New insights into the role of Runx1 in epithelial stem cell biology and pathology.

Authors:  Cornelia Johanna Franziska Scheitz; Tudorita Tumbar
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

10.  Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.

Authors:  Yun-Ji Jeung; Han-Gyeul Kim; Jiwon Ahn; Ho-Joon Lee; Sae-Bhom Lee; Misun Won; Cho-Rock Jung; Joo-Young Im; Bo-Kyung Kim; Seung-Kiel Park; Myung Jin Son; Kyung-Sook Chung
Journal:  Biochim Biophys Acta       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.